Dorsey Wright & Associates Has $3.85 Million Stake in Leidos Holdings, Inc. (NYSE:LDOS)

Dorsey Wright & Associates lowered its stake in Leidos Holdings, Inc. (NYSE:LDOS) by 0.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 26,709 shares of the aerospace company’s stock after selling 118 shares during the period. Dorsey Wright & Associates’ holdings in Leidos were worth $3,848,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of LDOS. Hobbs Group Advisors LLC boosted its stake in shares of Leidos by 3.5% in the 4th quarter. Hobbs Group Advisors LLC now owns 6,561 shares of the aerospace company’s stock valued at $945,000 after purchasing an additional 222 shares during the last quarter. Allstate Corp bought a new position in Leidos in the fourth quarter valued at approximately $538,000. Horizon Investment Services LLC raised its position in shares of Leidos by 18.6% during the 4th quarter. Horizon Investment Services LLC now owns 15,333 shares of the aerospace company’s stock valued at $2,209,000 after acquiring an additional 2,405 shares during the last quarter. denkapparat Operations GmbH acquired a new position in shares of Leidos in the 4th quarter valued at $277,000. Finally, Pictet Asset Management Holding SA boosted its position in shares of Leidos by 2.9% in the 4th quarter. Pictet Asset Management Holding SA now owns 65,452 shares of the aerospace company’s stock worth $9,429,000 after purchasing an additional 1,852 shares during the last quarter. Institutional investors and hedge funds own 76.12% of the company’s stock.

Insiders Place Their Bets

In other news, Director Gary Stephen May sold 2,128 shares of the business’s stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $131.24, for a total transaction of $279,278.72. Following the transaction, the director now directly owns 11,264 shares in the company, valued at $1,478,287.36. The trade was a 15.89 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Robert C. Kovarik, Jr. sold 1,511 shares of the firm’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $134.56, for a total transaction of $203,320.16. Following the completion of the sale, the director now owns 6,408 shares of the company’s stock, valued at $862,260.48. This trade represents a 19.08 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.96% of the company’s stock.

Leidos Price Performance

Shares of LDOS opened at $133.95 on Friday. The company has a 50 day moving average of $137.51 and a 200-day moving average of $153.64. The company has a quick ratio of 1.13, a current ratio of 1.21 and a debt-to-equity ratio of 0.91. The stock has a market capitalization of $17.17 billion, a P/E ratio of 14.50, a P/E/G ratio of 1.65 and a beta of 0.72. Leidos Holdings, Inc. has a twelve month low of $123.23 and a twelve month high of $202.90.

Leidos (NYSE:LDOS) last released its earnings results on Tuesday, February 11th. The aerospace company reported $2.37 earnings per share for the quarter, beating analysts’ consensus estimates of $2.24 by $0.13. Leidos had a net margin of 7.53% and a return on equity of 30.93%. As a group, equities research analysts forecast that Leidos Holdings, Inc. will post 10.62 EPS for the current fiscal year.

Leidos Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 28th. Investors of record on Friday, March 14th were given a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, March 14th. This represents a $1.60 annualized dividend and a yield of 1.19%. Leidos’s dividend payout ratio (DPR) is presently 17.32%.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. TD Cowen lowered Leidos from a “buy” rating to a “hold” rating and cut their target price for the company from $200.00 to $165.00 in a research note on Wednesday, January 8th. StockNews.com lowered shares of Leidos from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 8th. Wells Fargo & Company cut their target price on shares of Leidos from $197.00 to $191.00 and set an “overweight” rating on the stock in a report on Wednesday, February 26th. William Blair lowered shares of Leidos from an “outperform” rating to a “market perform” rating in a report on Friday, February 21st. Finally, UBS Group dropped their price objective on Leidos from $162.00 to $156.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 12th. Six analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $178.07.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.